Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer

Summary

The purpose of this study is to evaluate the safety, tolerability, compliance and mechanism of action of study drug (QBKPN SSI) in subjects with two or more second primary pre-invasive or invasive adenocarcinoma following surgical section of Stage 1 NSCLC.

Timeline

Start

2014-12

Primary completion

2015-11

Completion

2015-11

Drugs

Indications